BACKGROUND: In past research, procalcitonin (PCT) and glial fibrillary acidic protein (GFAP) have been reported to be useful biomarkers in predicting neurological outcome after the return of spontaneous circulation (ROSC) following out-of-hospital cardiac arrest (CA), although they have only been studied separately. In this study, we compared the usefulness of PCT and GFAP in predicting neurological outcome. METHODS: This study was a retrospective, single-center analysis, conducted in the intensive-care unit of a university hospital. Twenty-one sequential post-CA patients were included. Serum samples were collected from patients at 12 and 24 h after ROSC. Serum PCT and GFAP were measured and compared in patients with favorable and unfavorable neurological outcomes, evaluated at 6 months using the Glasgow-Pittsburgh Cerebral Performance Categories. RESULTS: Serum PCT was significantly higher at 12 and 24 h in patients with unfavorable outcomes (P = 0.004 and 0.002, respectively). Serum GFAP was not significantly higher at 12 and 24 h in patients with unfavorable outcomes (P = 0.118 and 0.079, respectively). The combination of PCT and GFAP showed high predictive value for unfavorable outcomes (86.7% sensitivity and 100% specificity at 12 h; 100% sensitivity and 83.3% specificity at 24 h). CONCLUSION: Serum PCT is a marker of unfavorable neurological outcome in post-CA patients, and is superior to serum GFAP in the early phase.
BACKGROUND: In past research, procalcitonin (PCT) and glial fibrillary acidic protein (GFAP) have been reported to be useful biomarkers in predicting neurological outcome after the return of spontaneous circulation (ROSC) following out-of-hospital cardiac arrest (CA), although they have only been studied separately. In this study, we compared the usefulness of PCT and GFAP in predicting neurological outcome. METHODS: This study was a retrospective, single-center analysis, conducted in the intensive-care unit of a university hospital. Twenty-one sequential post-CA patients were included. Serum samples were collected from patients at 12 and 24 h after ROSC. Serum PCT and GFAP were measured and compared in patients with favorable and unfavorable neurological outcomes, evaluated at 6 months using the Glasgow-Pittsburgh Cerebral Performance Categories. RESULTS: Serum PCT was significantly higher at 12 and 24 h in patients with unfavorable outcomes (P = 0.004 and 0.002, respectively). Serum GFAP was not significantly higher at 12 and 24 h in patients with unfavorable outcomes (P = 0.118 and 0.079, respectively). The combination of PCT and GFAP showed high predictive value for unfavorable outcomes (86.7% sensitivity and 100% specificity at 12 h; 100% sensitivity and 83.3% specificity at 24 h). CONCLUSION: Serum PCT is a marker of unfavorable neurological outcome in post-CA patients, and is superior to serum GFAP in the early phase.
Authors: Linda E Pelinka; Harald Hertz; Walter Mauritz; Naoki Harada; Mohammad Jafarmadar; Manfred Albrecht; Heinz Redl; Soheyl Bahrami Journal: Shock Date: 2005-08 Impact factor: 3.454
Authors: Linda E Pelinka; Alfred Kroepfl; Martin Leixnering; Walter Buchinger; Andreas Raabe; Heinz Redl Journal: J Neurotrauma Date: 2004-11 Impact factor: 5.269
Authors: Said Hachimi-Idrissi; Marcel Van der Auwera; Johan Schiettecatte; Guy Ebinger; Yvette Michotte; Luc Huyghens Journal: Resuscitation Date: 2002-06 Impact factor: 5.262
Authors: Melania M Bembea; William Savage; John J Strouse; Jamie McElrath Schwartz; Ernest Graham; Carol B Thompson; Allen Everett Journal: Pediatr Crit Care Med Date: 2011-09 Impact factor: 3.624
Authors: Carl Muroi; Johanna B Lemb; Michael Hugelshofer; Martin Seule; David Bellut; Emanuela Keller Journal: Neurocrit Care Date: 2014-08 Impact factor: 3.210
Authors: Ericka L Fink; Rachel P Berger; Robert S B Clark; R Scott Watson; Derek C Angus; Ashok Panigrahy; Rudolph Richichi; Clifton W Callaway; Michael J Bell; Stefania Mondello; Ronald L Hayes; Patrick M Kochanek Journal: Resuscitation Date: 2016-02-06 Impact factor: 5.262
Authors: Julia Hasslacher; Georg Franz Lehner; Ulrich Harler; Ronny Beer; Hanno Ulmer; Rudolf Kirchmair; Reiner Fischer-Colbrie; Romuald Bellmann; Stefan Dunzendorfer; Michael Joannidis Journal: Intensive Care Med Date: 2014-08-20 Impact factor: 17.440
Authors: Pascal Stammet; Yvan Devaux; Francisco Azuaje; Christophe Werer; Christiane Lorang; Georges Gilson; Martin Max Journal: Crit Care Res Pract Date: 2011-10-26